Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2013-04-08 13:55:22
Reporting Period:
Filing Date:
Accepted Time:
2013-04-08 13:55:22
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1362703 Pediatrx Inc. PEDX Pharmaceutical Preparations (2834) 202590810
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421882 Cameron Durrant 90 Fairmount Road West
Califon NJ 07830-3330
President, Ceo, Cfo, Treasurer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-04-05 4,250,000 $0.01 0 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,250,000 Direct
  1. 2,833,333 shares of common stock are subject to the terms of a lockup agreement dated February 9, 2011, to be released December 31, 2015.
  2. 4,250,000 of the shares were to be held in escrow pursuant to a management stock agreement dated July 1, 2010. This agreement was cancelled pursuant to a cancellation agreement dated effective July 1, 2010.